Bidirectional association between gastroesophageal reflux disease and depression: Two different nested case-control studies using a national sample cohort (original) (raw)

Introduction

Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders[1](/articles/s41598-018-29629-7#ref-CR1 "Savarino, E. et al. Epidemiology and natural history of gastroesophageal reflux disease. Minerva Gastroenterol Dietol 63, 175–183, https://doi.org/10.23736/S1121-421X.17.02383-2

               (2017)."). The upward movement of gastric contents into the esophagus causes troublesome symptoms and/or complications[1](/articles/s41598-018-29629-7#ref-CR1 "Savarino, E. et al. Epidemiology and natural history of gastroesophageal reflux disease. Minerva Gastroenterol Dietol 63, 175–183, 
                https://doi.org/10.23736/S1121-421X.17.02383-2
                
               (2017)."). The prevalence of GERD is approximately 18.1–27.8% in North America, 8.8–25.9% in Europe, 2.5–7.8% in East Asia[2](/articles/s41598-018-29629-7#ref-CR2 "El-Serag, H. B., Sweet, S., Winchester, C. C. & Dent, J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63, 871–880, 
                https://doi.org/10.1136/gutjnl-2012-304269
                
               (2014)."), and 4.6–7.3% in Korea[3](/articles/s41598-018-29629-7#ref-CR3 "Kim, K. M. et al. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. J Gastroenterol Hepatol 27, 741–745, 
                https://doi.org/10.1111/j.1440-1746.2011.06921.x
                
               (2012)."). The pathogenesis of GERD is multifactorial. Hypotension of the lower esophageal sphincter, delayed acid clearance of the esophagus, and increased esophagogastric junction compliance have all been suggested as possible pathogenic factors[4](/articles/s41598-018-29629-7#ref-CR4 "Boeckxstaens, G., El-Serag, H. B., Smout, A. J. & Kahrilas, P. J. Symptomatic reflux disease: the present, the past and the future. Gut 63, 1185–1193, 
                https://doi.org/10.1136/gutjnl-2013-306393
                
               (2014).").

Depression is one of the most common diseases among humans5. The prevalence of depression is approximately 7.6% in the USA6 and 11% in the UK[7](/articles/s41598-018-29629-7#ref-CR7 "Martin-Merino, E., Ruigomez, A., Johansson, S., Wallander, M. A. & Garcia-Rodriguez, L. A. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry 12, PCC 08m00764, https://doi.org/10.4088/PCC.08m00764blu

               (2010)."). In Korea, the lifetime prevalence of major depressive disorder is 6.7% and has increased by 0.2% annually[8](/articles/s41598-018-29629-7#ref-CR8 "Hj, J. Epidemiologic studies on depression and suicide. J Korean Med Assoc 55, 322–328 (2012)."). Depression influences various diseases, such as cardiovascular disease and diabetes mellitus[9](/articles/s41598-018-29629-7#ref-CR9 "Aina, Y. & Susman, J. L. Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc 106, S9–14 (2006)."). Previous studies have reported an association between depression and GERD[10](#ref-CR10 "Lin, W. S. et al. Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study. Plos One 9, e107694, 
                https://doi.org/10.1371/journal.pone.0107694
                
               (2014)."),[11](#ref-CR11 "Chou, P. H. et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics 55, 155–162, 
                https://doi.org/10.1016/j.psym.2013.06.003
                
               (2014)."),[12](#ref-CR12 "You, Z. H. et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med 26, 534–539, 
                https://doi.org/10.1016/j.ejim.2015.05.005
                
               (2015)."),[13](/articles/s41598-018-29629-7#ref-CR13 "Jansson, C. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26, 683–691, 
                https://doi.org/10.1111/j.1365-2036.2007.03411.x
                
               (2007)."). Anxiety or depression have been reported to increase the risk of GERD in some studies[14](/articles/s41598-018-29629-7#ref-CR14 "Yang, X. J., Jiang, H. M., Hou, X. H. & Song, J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol 21, 4302–4309, 
                https://doi.org/10.3748/wjg.v21.i14.4302
                
               (2015)."),[15](/articles/s41598-018-29629-7#ref-CR15 "Javadi, S. & Shafikhani, A. A. Anxiety and depression in patients with gastroesophageal reflux disorder. Electron Physician 9, 5107–5112, 
                https://doi.org/10.19082/5107
                
               (2017)."), whereas other studies have suggested that GERD increases the risk of depression[10](/articles/s41598-018-29629-7#ref-CR10 "Lin, W. S. et al. Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study. Plos One 9, e107694, 
                https://doi.org/10.1371/journal.pone.0107694
                
               (2014)."),[12](/articles/s41598-018-29629-7#ref-CR12 "You, Z. H. et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med 26, 534–539, 
                https://doi.org/10.1016/j.ejim.2015.05.005
                
               (2015)."). Some cross-sectional studies have also reported this association[11](/articles/s41598-018-29629-7#ref-CR11 "Chou, P. H. et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics 55, 155–162, 
                https://doi.org/10.1016/j.psym.2013.06.003
                
               (2014)."),[13](/articles/s41598-018-29629-7#ref-CR13 "Jansson, C. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26, 683–691, 
                https://doi.org/10.1111/j.1365-2036.2007.03411.x
                
               (2007)."); therefore, the direction of the effect is not clear. Verifying the direction of the association between GERD and depression is important because it may affect the approach to managing patients diagnosed with both diseases, as these patients are frequently treated in clinics.

The purpose of this study is to evaluate the associations between GERD and depression using a national sample cohort of the Korean population. Therefore, we designed two different nested case-control studies. In one study, we extracted data from patients with depression and their 1:4 matched controls (study I) and analyzed their previous histories of GERD. In the other study, we obtained data from patients with GERD and their 1:2 matched controls (study II) and analyzed their previous histories of depression.

Results

Study I

The rate of GERD was higher in the depression group (16.3% [9,959/60,957]) than in the control I group (9.0% [21,963/197,904], P < 0.001, Table 1). The general characteristics (age, sex, income, region of residence, and histories of hypertension, diabetes, and dyslipidemia) of the participants were exactly the same after matching (P = 1.000). Higher rates of ischemic heart disease and cerebral stroke were observed in the depression group (all, P < 0.05).

Table 1 General characteristics of the participants.

Full size table

The crude and adjusted odds ratios (ORs) for GERD were 1.97 (95% confidence interval (CI) = 1.92–2.02) and 2.01 (95% CI = 1.96–2.07), respectively, in the depression group (P < 0.001, Table 2).

Table 2 Crude and adjusted ORs (95% CI) for GERD in patients with depression.

Full size table

In the subgroup analyses, higher crude and adjusted ORs for GERD were observed in the depression group (P < 0.05, Table 3). The adjusted ORs were 2.35 (95% CI = 2.10–2.63) in men <40 years old; 2.05 (95% CI = 1.91–2.21) in women <40 years old; 2.17 (95% CI = 2.03–2.33) in men 40–59 years old; 1.99 (95% CI = 1.90–2.09) in women 40–59 years old; 1.99 (95% CI = 1.85–2.15) in men ≥60 years old; and 1.90 (95% CI = 1.81–2.01) in women ≥60 years old.

Table 3 Subgroup analysis of crude and adjusted ORs (95% CI) for GERD in patients with depression stratified according to age and sex.

Full size table

Study II

A higher rate of depression was observed in the GERD group (5.7% [7,625/133,089]) than in the control II group (3.9% [10,474/266,178], P < 0.001, Table 1). The general characteristics (age, sex, income, region of residence, and histories of hypertension, diabetes, and dyslipidemia) of the participants were exactly the same after matching (P = 1.000). Higher rates of ischemic heart disease and cerebral stroke were observed in the GERD group (all, P < 0.05).

The crude and adjusted ORs for depression were 1.48 (95% CI = 1.44–1.53) and 1.48 (95% CI = 1.43–1.52), respectively, in the GERD group (P < 0.001, Table 4).

Table 4 Crude and adjusted ORs (95% CI) for depression in patients with GERD.

Full size table

In the subgroup analyses, higher crude and adjusted ORs for depression were recorded in the GERD group (P < 0.001, Table 5). The adjusted ORs were 1.44 (95% CI = 1.27–1.63) in men <40 years old; 1.64 (95% CI = 1.50–1.78) in women <40 years old; 1.51 (95% CI = 1.40–1.64) in men 40–59 years old; 1.47 (95% CI = 1.40–1.55) in women 40–59 years old; 1.39 (95% CI = 1.26–1.53) in men ≥60 years old; and 1.43 (95% CI = 1.34–1.52) in women ≥60 years old.

Table 5 Subgroup analysis of crude and adjusted ORs (95% CI) for depression in patients with GERD stratified according to age and sex.

Full size table

Discussion

Higher ORs for GERD were observed in the depression group. Moreover, the ORs for depression were higher in patients with GERD. Because the general characteristics of the extracted study population were different in study I and study II, the ORs (OR for GERD in patients with depression; OR for depression in patients with GERD) were not the same in study I and study II. In both studies, these relationships were consistent in the subgroup analyses stratified according to age and sex. To our knowledge, this study is the first to confirm the bidirectionality of these associations using two different cohorts. Because the two diseases are associated, clinicians treating one disease should consider the presence of the other disease.

The results of this study were similar to those of previous studies. The incidence ratio for depression was 2.29 (95% CI = 1.58–3.36) in patients with GERD in a previous study[10](/articles/s41598-018-29629-7#ref-CR10 "Lin, W. S. et al. Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study. Plos One 9, e107694, https://doi.org/10.1371/journal.pone.0107694

               (2014)."), and another study revealed that the hazard ratio for depression was 3.37 (95% CI = 2.49–4.57) in patients with GERD[12](/articles/s41598-018-29629-7#ref-CR12 "You, Z. H. et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med 26, 534–539, 
                https://doi.org/10.1016/j.ejim.2015.05.005
                
               (2015)."). Here, the adjusted OR for GERD in patients with depression was 2.01 (95% CI = 1.96–2.07) in study I. Previous studies have reported ORs of 1.7 (95% CI = 1.4–2.1)[13](/articles/s41598-018-29629-7#ref-CR13 "Jansson, C. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26, 683–691, 
                https://doi.org/10.1111/j.1365-2036.2007.03411.x
                
               (2007).") and 3.16 (95% CI = 2.71–3.68)[11](/articles/s41598-018-29629-7#ref-CR11 "Chou, P. H. et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics 55, 155–162, 
                https://doi.org/10.1016/j.psym.2013.06.003
                
               (2014).") for GERD in patients with depression. Here, the adjusted OR for depression in patients with GERD was 1.48 (95% CI = 1.43–1.52) in study II.

We have identified several possible explanations for the observation that GERD increased the risk of depression. First, the esophageal mucosa of patients with GERD contains large amounts of cytokines, such as interleukin (IL)-6, IL-8, IL-1beta, interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α)[16](/articles/s41598-018-29629-7#ref-CR16 "Altomare, A., Guarino, M. P., Cocca, S., Emerenziani, S. & Cicala, M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol 19, 6523–6528, https://doi.org/10.3748/wjg.v19.i39.6523

               (2013)."). The increased levels of these immune mediators in peripheral organs might be associated with the upregulation of central nervous system inflammation[17](/articles/s41598-018-29629-7#ref-CR17 "Lampa, J. et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci USA 109, 12728–12733, 
                https://doi.org/10.1073/pnas.1118748109
                
               (2012)."), which might affect depression and bipolar disorder[18](/articles/s41598-018-29629-7#ref-CR18 "Berk, M. et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11, 200, 
                https://doi.org/10.1186/1741-7015-11-200
                
               (2013)."),[19](/articles/s41598-018-29629-7#ref-CR19 "Goldstein, B. I., Kemp, D. E., Soczynska, J. K. & McIntyre, R. S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 70, 1078–1090, 
                https://doi.org/10.4088/JCP.08r04505
                
               (2009)."). Second, frequent arousal by GERD might activate the autonomic nervous system and increase sympathetic activation[20](/articles/s41598-018-29629-7#ref-CR20 "Jansson, C. et al. A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol 7, 960–965, 
                https://doi.org/10.1016/j.cgh.2009.03.007
                
               (2009)."). Acid reflux stimulates the vagus nerve and triggers bronchoconstriction[21](/articles/s41598-018-29629-7#ref-CR21 "Demeter, P. & Pap, A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol 39, 815–820, 
                https://doi.org/10.1007/s00535-004-1416-8
                
               (2004)."), which could result in sleep disorders and affect mood disorders[22](/articles/s41598-018-29629-7#ref-CR22 "Altena, E. et al. The bidirectional relation between emotional reactivity and sleep: From disruption to recovery. Behav Neurosci 130, 336–350, 
                https://doi.org/10.1037/bne0000128
                
               (2016)."). Third, the reflux symptom itself could result in depression if patients are constantly feeling upset about their condition[23](/articles/s41598-018-29629-7#ref-CR23 "Kamolz, T. & Velanovich, V. Psychological and emotional aspects of gastroesophageal reflux disease. Diseases of the Esophagus 15, 199–203 (2002).").

Depression might also increase the risk of GERD. First, the fear of reflux symptoms might increase the individual’s perception of reflux symptoms23. Psychological factors could reduce the sensation threshold in the body23 and increase the sensation of esophageal stimulation[24](/articles/s41598-018-29629-7#ref-CR24 "Johnston, B. T. Stress and heartburn. J Psychosom Res 59, 425–426, https://doi.org/10.1016/j.jpsychores.2005.05.011

               (2005)."). Second, depression might actually increase reflux. Psychological factors can decrease the pressure of the lower esophageal sphincter[23](/articles/s41598-018-29629-7#ref-CR23 "Kamolz, T. & Velanovich, V. Psychological and emotional aspects of gastroesophageal reflux disease. Diseases of the Esophagus 15, 199–203 (2002)."), change esophageal motility[23](/articles/s41598-018-29629-7#ref-CR23 "Kamolz, T. & Velanovich, V. Psychological and emotional aspects of gastroesophageal reflux disease. Diseases of the Esophagus 15, 199–203 (2002)."), increase gastric acid secretion[24](/articles/s41598-018-29629-7#ref-CR24 "Johnston, B. T. Stress and heartburn. J Psychosom Res 59, 425–426, 
                https://doi.org/10.1016/j.jpsychores.2005.05.011
                
               (2005)."), and decrease acid clearance in the esophagus[24](/articles/s41598-018-29629-7#ref-CR24 "Johnston, B. T. Stress and heartburn. J Psychosom Res 59, 425–426, 
                https://doi.org/10.1016/j.jpsychores.2005.05.011
                
               (2005)."). Third, antidepressant medication might aggravate reflux[25](/articles/s41598-018-29629-7#ref-CR25 "Martin-Merino, E., Ruigomez, A., Garcia Rodriguez, L. A., Wallander, M. A. & Johansson, S. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 31, 1132–1140, 
                https://doi.org/10.1111/j.1365-2036.2010.04280.x
                
               (2010)."). Anticholinergic drugs may lower the pressure of the lower esophageal sphincter[26](/articles/s41598-018-29629-7#ref-CR26 "Brahm, N. C. & Kelly-Rehm, M. C. Antidepressant-mediated gastroesophageal reflux disease. Consult Pharm 26, 274–278, 
                https://doi.org/10.4140/TCP.n.2011.274
                
               (2011)."). Moreover, drugs have been shown to delay gastric emptying, inhibit esophageal peristalsis, and decrease salivary secretion[25](/articles/s41598-018-29629-7#ref-CR25 "Martin-Merino, E., Ruigomez, A., Garcia Rodriguez, L. A., Wallander, M. A. & Johansson, S. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 31, 1132–1140, 
                https://doi.org/10.1111/j.1365-2036.2010.04280.x
                
               (2010).").

Furthermore, confounders such as obesity, eating habits, smoking, alcohol drinking, lack of sleep, and high stress might aggravate both GERD and depression27,[28](/articles/s41598-018-29629-7#ref-CR28 "Ness-Jensen, E. & Lagergren, J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol 31, 501–508, https://doi.org/10.1016/j.bpg.2017.09.004

               (2017)."). Stress induces GERD[29](/articles/s41598-018-29629-7#ref-CR29 "Jansson, C., Wallander, M. A., Johansson, S., Johnsen, R. & Hveem, K. Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scand J Gastroenterol 45, 21–29, 
                https://doi.org/10.3109/00365520903401967
                
               (2010).") and promotes depression[30](/articles/s41598-018-29629-7#ref-CR30 "Proudfoot, J. et al. Triggers of mania and depression in young adults with bipolar disorder. J Affect Disord 143, 196–202, 
                https://doi.org/10.1016/j.jad.2012.05.052
                
               (2012).").

The advantages of this study are similar to those of our previous studies using the national sample cohort[31](#ref-CR31 "Choi, H. G., Park, B., Sim, S. & Ahn, S. H. Tonsillectomy Does Not Reduce Upper Respiratory Infections: A National Cohort Study. Plos One 11, e0169264, https://doi.org/10.1371/journal.pone.0169264

               (2016)."),[32](#ref-CR32 "Kim, S. Y. et al. Severe hearing impairment and risk of depression: A national cohort study. Plos One 12, e0179973, 
                https://doi.org/10.1371/journal.pone.0179973
                
               (2017)."),[33](/articles/s41598-018-29629-7#ref-CR33 "Kim, M. S., Kim, S. Y., Kim, J. H., Park, B. & Choi, H. G. Depression in breast cancer patients who have undergone mastectomy: A national cohort study. Plos One 12, e0175395, 
                https://doi.org/10.1371/journal.pone.0175395
                
               (2017)."). We used a large, representative nationwide population. Because the NHIS data include all citizens of the nation without exception, no participants were lost to follow-up. The control groups were randomly selected by matching for age, sex, income, region of residence, and past medical histories to avoid confounding effects. Furthermore, an adjusted regression model was used to minimize the influence of confounders. Because of the large number of participants, we maintained the statistical power in the split study design. Thus, we performed subgroup analyses. Moreover, we performed two different studies. Because of the cohort study design, we could differentiate whether GERD or depression might initiate the relationship.

This study has several limitations. Despite the cohort study design, we were not able to exclude the effects of possible confounders that might affect both GERD and depression. Because data on body mass index, smoking, alcohol, and sleep habits were not available, we could not adjust for these factors. We were not able to analyze the severity of both GERD and depression, and patients who did not consult a clinician may have been missed. Because of the nested case-control study design, the ORs between risk factors (independent variable) and results (dependent variable) should be interpreted carefully. Because the participants were selected using ICD-10 codes, this study has the possibility of over- or underestimation of the associations examined. We considered GERD on the basis of diagnostic codes and treatment histories without endoscopic findings. Therefore, we were not able to determine whether these patients had only symptomatic GERD or erosive GERD.

The ORs for GERD were higher in patients with depression, and higher ORs for depression were also observed in patients with GERD. These associations were consistent among different age groups and sexes.

Materials and Methods

Study Population and Data Collection

This study was approved by the ethics committee of Hallym University (2014-I148). The Institutional Review Board excused the requirement to obtain written informed consent from study participants. Every survey reported in this study was conducted in agreement with the guidelines of the ethics committee of Hallym University.

The present study was based on data from the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC). To minimize nonsampling errors, the samples were extracted exactly from the mother population of the Korean NHIS. Approximately 2% (one million) of the whole Korean population (50 million) was chosen. These sampled data represent the mother population obtained by stratified systemic sampling methods. The selected population was classified at 1,476 levels (age [18 categories], sex [2 categories], and income level [41 categories]). The validity of the sample cohort was confirmed in a previous study[34](/articles/s41598-018-29629-7#ref-CR34 "Lee, J., Lee, J. S., Park, S. H., Shin, S. A. & Kim, K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. International journal of epidemiology. https://doi.org/10.1093/ije/dyv319

               (2016)."). The specific procedures for sampling the cohort are described on the website of the National Health Insurance Sharing Service[35](/articles/s41598-018-29629-7#ref-CR35 "National Health Insurance Sharing Service, 
                http://nhiss.nhis.or.kr/
                
               (2015)."). This cohort database comprises detailed medical management histories for every participant from 2002 to 2013: (i) personal information, (ii) health insurance claim codes (procedures and prescriptions), (iii) diagnostic codes using the International Classification of Disease-10 (ICD-10), (iv) death records from the Korean National Statistical Office (using the Korean Standard Classification of Disease), (v) socio-economic data (residence and income), and (vi) medical examination data

The precise population statistics were derived using these NHIS data. The Korean Health Insurance System is mandatory for all Koreans. Using the Health Insurance Review & Assessment (HIRA) system, all medical records can be traced without exception in Korea. Moreover, the possible overlapping of medical records was minimized, even when a patient moved to a different region of residence. All patients are registered using a 13-digit registration number in Korea. The 13-digit registration number is legally issued to every Korean for life. The death of a patient must be reported to an administrative entity before a funeral is conducted. The date and cause of death are listed on a death certificate issued by medical doctors.

Participant Selection

All 1,125,691 patients with 114,369,638 medical claim codes were used in this study. Among these participants, patients with depression were included. Depression was diagnosed based on the ICD-10 codes F31 (bipolar affective disorder) through F39 (unspecified mood disorder) by a psychiatrist from 2002 through 2013[33](/articles/s41598-018-29629-7#ref-CR33 "Kim, M. S., Kim, S. Y., Kim, J. H., Park, B. & Choi, H. G. Depression in breast cancer patients who have undergone mastectomy: A national cohort study. Plos One 12, e0175395, https://doi.org/10.1371/journal.pone.0175395

               (2017)."),[36](/articles/s41598-018-29629-7#ref-CR36 "Choi, H. G., Lee, M. J. & Lee, S. M. Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort. Sci Rep 8, 2083, 
                https://doi.org/10.1038/s41598-018-20374-5
                
               (2018)."). Only participants who were treated ≥2 times were included (n = 68,019).

GERD was selected using the ICD-10 code K21 during the same periods considered for depression[37](/articles/s41598-018-29629-7#ref-CR37 "Lee, Y. S., Jang, B. H., Ko, S. G. & Chae, Y. Comorbid risks of psychological disorders and gastroesophageal reflux disorder using the national health insurance service-National Sample Cohort: A STROBE-compliant article. Medicine (Baltimore) 97, e0153, https://doi.org/10.1097/MD.0000000000010153

               (2018)."). Patients who were treated ≥2 times and were prescribed a proton pump inhibitor (PPI) for ≥2 weeks were included (n = 137,807).

Study I

The participants in the control I group, who were never treated for depression during the same period, were matched 1:4 with the participants with depression for age, group, sex, income group, region of residence, and past medical histories (hypertension, diabetes, and dyslipidemia). These participants were extracted from the mother population (n = 1,057,672). The participants in the control I group were arranged using a random number order and then chosen in descending order. The control I participants and participants with depression were presumed to be concurrently enrolled in this study (index date). Thus, participants who died before the index date were excluded from the control group. Participants with depression for whom we were not able to identify a sufficient number of matching participants were excluded (n = 621). Participants aged less than 20 years were also excluded (n = 6,441). Ultimately, 60,957 participants with depression participants and 243,828 control I participants were included (Fig. 1a). However, the past medical histories of ischemic heart disease or cerebral stroke were not matched because such rigorous matching elevated the dropout rate due to the absence of control participants. Using these matched groups, we investigated the previous histories of GERD in both the depression and control I groups.

Figure 1

figure 1

A schematic illustration of the participant selection process used in the present study. (a) Of the 1,125,691 total participants, 60,957 participants with depression were matched with 243,828 control I participants for age, group, sex, income group, region of residence, and past medical histories. (b) Of the 1,125,691 total participants, 133,089 participants with GERD were matched with 266,178 control II participants for age, group, sex, income group, region of residence, and past medical histories.

Full size image

Study II

The participants in the control II group, who were never diagnosed with GERD, were matched 1:2 with the GERD participants from 2002 through 2013 in this cohort. The control groups were extracted from the mother population (n = 987,884). The age, group, sex, income group, region of residence, and past medical histories (hypertension, diabetes, and dyslipidemia) were matched between the participants with GERD and the control II group. The control II participants were arranged using another set of random numbers and then chosen in descending order to minimize selection bias. The control II participants and participants with depression were presumed to be concurrently enrolled in this study (index date). Thus, participants who died before the index date were excluded. The participants with GERD for whom we were not able to identify a sufficient number of matching participants were excluded (n = 1,576). Participants aged less than 20 years were also excluded (n = 3,142). As a result, 133,089 participants with GERD and 266,178 control II participants were included (Fig. 1b). However, the past medical histories of ischemic heart disease and cerebral stroke were not matched for the same reason mentioned above. The previous histories of depression in both the GERD and control II groups were analyzed.

Variables

Age groups were categorized in 5-year intervals: 20–24, 25–29, 30–34…, and 85+ years old. Fourteen age groups were classified. The income groups were initially classified into 41 classes (one health aid class, 20 self-employment health insurance classes, and 20 employment health insurance classes). These groups were then integrated into 11 classes (class 1 [lowest income]-11 [highest income]). Region of residence was classified into 16 areas in accordance with administrative areas. These regions were further classified into urban (Seoul, Busan, Daegu, Incheon, Gwangju, Daejeon, and Ulsan) and rural (Gyeonggi, Gangwon, Chungcheongbuk, Chungcheongnam, Jeollabuk, Jeollanam, Gyeongsangbuk, Gyeongsangnam, and Jeju) areas.

The ICD-10 codes were used to identify the past medical histories. For a precise diagnosis, participants who were treated ≥2 times for hypertension (I10 and I15), diabetes (E10-E14), and dyslipidemia (E78) were included in these categories. Ischemic heart disease (I24 and I25) and cerebral stroke (I60-I66) were included if the participants were treated ≥1 time.

Statistical analyses

An unconditional logistic regression analysis was conducted to analyze the ORs for GERD in the patients with depression in study I. Another unconditional logistic regression analysis was conducted to analyze the ORs for depression in patients with GERD in study II. Crude (simple) and adjusted (age, sex, income, region of residence, and histories of hypertension, diabetes, dyslipidemia, ischemic heart disease, and cerebral stroke) models were employed, and 95% CIs were determined.

Subgroup analyses were performed according to age and sex (<40 years old, 40–59 years old, and ≥60 years old; men and women).

Two-tailed analyses were used, and P values less than 0.05 were defined as indicating a statistically significant difference. The SPSS v. 22.0 software was used for statistical analyses (IBM, Armonk, NY, USA).

References

  1. Savarino, E. et al. Epidemiology and natural history of gastroesophageal reflux disease. Minerva Gastroenterol Dietol 63, 175–183, https://doi.org/10.23736/S1121-421X.17.02383-2 (2017).
    Article PubMed Google Scholar
  2. El-Serag, H. B., Sweet, S., Winchester, C. C. & Dent, J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63, 871–880, https://doi.org/10.1136/gutjnl-2012-304269 (2014).
    Article PubMed Google Scholar
  3. Kim, K. M. et al. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. J Gastroenterol Hepatol 27, 741–745, https://doi.org/10.1111/j.1440-1746.2011.06921.x (2012).
    Article PubMed Google Scholar
  4. Boeckxstaens, G., El-Serag, H. B., Smout, A. J. & Kahrilas, P. J. Symptomatic reflux disease: the present, the past and the future. Gut 63, 1185–1193, https://doi.org/10.1136/gutjnl-2013-306393 (2014).
    Article PubMed PubMed Central Google Scholar
  5. Ustun, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C. & Murray, C. J. Global burden of depressive disorders in the year 2000. Br J Psychiatry 184, 386–392 (2004).
    Article PubMed CAS Google Scholar
  6. Pratt, L. A. & Brody, D. J. Depression in the U.S. household population, 2009–2012. NCHS Data Brief, 1–8 (2014).
  7. Martin-Merino, E., Ruigomez, A., Johansson, S., Wallander, M. A. & Garcia-Rodriguez, L. A. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry 12, PCC 08m00764, https://doi.org/10.4088/PCC.08m00764blu (2010).
  8. Hj, J. Epidemiologic studies on depression and suicide. J Korean Med Assoc 55, 322–328 (2012).
    Article Google Scholar
  9. Aina, Y. & Susman, J. L. Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc 106, S9–14 (2006).
    PubMed Google Scholar
  10. Lin, W. S. et al. Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study. Plos One 9, e107694, https://doi.org/10.1371/journal.pone.0107694 (2014).
    Article ADS PubMed PubMed Central CAS Google Scholar
  11. Chou, P. H. et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics 55, 155–162, https://doi.org/10.1016/j.psym.2013.06.003 (2014).
    Article PubMed Google Scholar
  12. You, Z. H. et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med 26, 534–539, https://doi.org/10.1016/j.ejim.2015.05.005 (2015).
    Article PubMed Google Scholar
  13. Jansson, C. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 26, 683–691, https://doi.org/10.1111/j.1365-2036.2007.03411.x (2007).
    Article PubMed CAS Google Scholar
  14. Yang, X. J., Jiang, H. M., Hou, X. H. & Song, J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol 21, 4302–4309, https://doi.org/10.3748/wjg.v21.i14.4302 (2015).
    Article PubMed PubMed Central Google Scholar
  15. Javadi, S. & Shafikhani, A. A. Anxiety and depression in patients with gastroesophageal reflux disorder. Electron Physician 9, 5107–5112, https://doi.org/10.19082/5107 (2017).
    Article PubMed PubMed Central Google Scholar
  16. Altomare, A., Guarino, M. P., Cocca, S., Emerenziani, S. & Cicala, M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol 19, 6523–6528, https://doi.org/10.3748/wjg.v19.i39.6523 (2013).
    Article PubMed PubMed Central Google Scholar
  17. Lampa, J. et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci USA 109, 12728–12733, https://doi.org/10.1073/pnas.1118748109 (2012).
    Article ADS PubMed Google Scholar
  18. Berk, M. et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11, 200, https://doi.org/10.1186/1741-7015-11-200 (2013).
    Article PubMed PubMed Central CAS Google Scholar
  19. Goldstein, B. I., Kemp, D. E., Soczynska, J. K. & McIntyre, R. S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 70, 1078–1090, https://doi.org/10.4088/JCP.08r04505 (2009).
    Article PubMed Google Scholar
  20. Jansson, C. et al. A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol 7, 960–965, https://doi.org/10.1016/j.cgh.2009.03.007 (2009).
    Article PubMed Google Scholar
  21. Demeter, P. & Pap, A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol 39, 815–820, https://doi.org/10.1007/s00535-004-1416-8 (2004).
    Article PubMed Google Scholar
  22. Altena, E. et al. The bidirectional relation between emotional reactivity and sleep: From disruption to recovery. Behav Neurosci 130, 336–350, https://doi.org/10.1037/bne0000128 (2016).
    Article PubMed CAS Google Scholar
  23. Kamolz, T. & Velanovich, V. Psychological and emotional aspects of gastroesophageal reflux disease. Diseases of the Esophagus 15, 199–203 (2002).
    Article PubMed CAS Google Scholar
  24. Johnston, B. T. Stress and heartburn. J Psychosom Res 59, 425–426, https://doi.org/10.1016/j.jpsychores.2005.05.011 (2005).
    Article PubMed Google Scholar
  25. Martin-Merino, E., Ruigomez, A., Garcia Rodriguez, L. A., Wallander, M. A. & Johansson, S. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 31, 1132–1140, https://doi.org/10.1111/j.1365-2036.2010.04280.x (2010).
    Article PubMed CAS Google Scholar
  26. Brahm, N. C. & Kelly-Rehm, M. C. Antidepressant-mediated gastroesophageal reflux disease. Consult Pharm 26, 274–278, https://doi.org/10.4140/TCP.n.2011.274 (2011).
    Article PubMed Google Scholar
  27. Avidan, B., Sonnenberg, A., Giblovich, H. & Sontag, S. J. Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 15, 1907–1912 (2001).
    Article PubMed CAS Google Scholar
  28. Ness-Jensen, E. & Lagergren, J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol 31, 501–508, https://doi.org/10.1016/j.bpg.2017.09.004 (2017).
    Article PubMed CAS Google Scholar
  29. Jansson, C., Wallander, M. A., Johansson, S., Johnsen, R. & Hveem, K. Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scand J Gastroenterol 45, 21–29, https://doi.org/10.3109/00365520903401967 (2010).
    Article PubMed Google Scholar
  30. Proudfoot, J. et al. Triggers of mania and depression in young adults with bipolar disorder. J Affect Disord 143, 196–202, https://doi.org/10.1016/j.jad.2012.05.052 (2012).
    Article PubMed Google Scholar
  31. Choi, H. G., Park, B., Sim, S. & Ahn, S. H. Tonsillectomy Does Not Reduce Upper Respiratory Infections: A National Cohort Study. Plos One 11, e0169264, https://doi.org/10.1371/journal.pone.0169264 (2016).
    Article PubMed PubMed Central CAS Google Scholar
  32. Kim, S. Y. et al. Severe hearing impairment and risk of depression: A national cohort study. Plos One 12, e0179973, https://doi.org/10.1371/journal.pone.0179973 (2017).
    Article PubMed PubMed Central CAS Google Scholar
  33. Kim, M. S., Kim, S. Y., Kim, J. H., Park, B. & Choi, H. G. Depression in breast cancer patients who have undergone mastectomy: A national cohort study. Plos One 12, e0175395, https://doi.org/10.1371/journal.pone.0175395 (2017).
    Article PubMed PubMed Central CAS Google Scholar
  34. Lee, J., Lee, J. S., Park, S. H., Shin, S. A. & Kim, K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. International journal of epidemiology. https://doi.org/10.1093/ije/dyv319 (2016).
    Article PubMed PubMed Central Google Scholar
  35. National Health Insurance Sharing Service, http://nhiss.nhis.or.kr/ (2015).
  36. Choi, H. G., Lee, M. J. & Lee, S. M. Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort. Sci Rep 8, 2083, https://doi.org/10.1038/s41598-018-20374-5 (2018).
    Article ADS PubMed PubMed Central CAS Google Scholar
  37. Lee, Y. S., Jang, B. H., Ko, S. G. & Chae, Y. Comorbid risks of psychological disorders and gastroesophageal reflux disorder using the national health insurance service-National Sample Cohort: A STROBE-compliant article. Medicine (Baltimore) 97, e0153, https://doi.org/10.1097/MD.0000000000010153 (2018).
    Article Google Scholar

Download references

Acknowledgements

This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and the Hallym University Research Fund (HURF-2017–34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Author notes

  1. So Young Kim and Hyung-Jong Kim contributed equally to this work.

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head & Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea
    So Young Kim
  2. Department of Otorhinolaryngology-Head & Neck Surgery, Hallym University College of Medicine, Anyang, Korea
    Hyung-Jong Kim, Il Gyu Kong & Hyo Geun Choi
  3. Department of Internal Medicine, Hallym University College of Medicine, Anyang, Korea
    Hyun Lim
  4. Department of Laboratory Medicine, Hallym University College of Medicine, Anyang, Korea
    Miyoung Kim

Authors

  1. So Young Kim
    You can also search for this author inPubMed Google Scholar
  2. Hyung-Jong Kim
    You can also search for this author inPubMed Google Scholar
  3. Hyun Lim
    You can also search for this author inPubMed Google Scholar
  4. Il Gyu Kong
    You can also search for this author inPubMed Google Scholar
  5. Miyoung Kim
    You can also search for this author inPubMed Google Scholar
  6. Hyo Geun Choi
    You can also search for this author inPubMed Google Scholar

Contributions

H.G.C. designed the study, participated in the collection and interpretation of data and revised the manuscript. S.Y.K. and H.J.K. participated in the interpretation of data and drafted and revised the manuscript. H.L., M.K. and I.G.K. participated in the analysis and interpretation of data and revised the manuscript. All authors approved the final version of the manuscript.

Corresponding author

Correspondence toHyo Geun Choi.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Kim, S.Y., Kim, HJ., Lim, H. et al. Bidirectional association between gastroesophageal reflux disease and depression: Two different nested case-control studies using a national sample cohort.Sci Rep 8, 11748 (2018). https://doi.org/10.1038/s41598-018-29629-7

Download citation